HEB, Harris-Teeter and other regional grocery stores and independently owned pharmacies nationwide from July 2024 through March 2025 for about $11. recalls
1 recall recorded since 2018, most recently on 10 April 2025. Status and classification are as published by the CPSC.
Recalls1
Ongoing (FDA)0
Terminated or completed0
Class I (FDA)0
Announced Consumer products
- Recall started
- 10 April 2025
- Reason
- The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.
- Remedy
- Consumers should immediately secure the product out of the sight and reach of children and contact Kramer Laboratories for information on how to return or dispose of the product for a full refund. Only the packaging is being recalled, not the medicine itself, but both should be disposed.
- Recall number
- 25223
- Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs
CPSC recall notice
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.